Pfizer Inc. (PFE) News and Global Healthcare & Biopharma Updates
Pfizer Inc., headquartered in New York City, is one of the world’s largest biopharmaceutical companies. Its portfolio spans vaccines, oncology, cardiology, and rare diseases. Known globally for developing the first widely distributed COVID-19 vaccine with BioNTech, Pfizer continues to advance innovation in immunology, mRNA technology, and breakthrough medicines to improve global health outcomes.
30.13
0.6900
2.34 %
At close
10/20
USD
Daily range
29.84
30.25
30.25
Weekly range
28.91
30.25
30.25
Pfizer stock climbs as buyer support persists amid infectious disease research spotlight
Pfizer Inc. (PFE) stock is trading at $29.12, up 2.63% for the day. The price sits above its key moving averages, suggesting strong participation from buyers across ...
Pfizer shares technical analysis: Breakout attempt at $28.55 resistance
Pfizer Inc. (PFE) stock is trading at $28.14, posting a daily gain of 3.27%. The price is positioned above its key moving averages, signaling sustained short- and ...
Menstrual migraine research spotlight as Pfizer stock edges higher
Pfizer says that not all migraine attacks are random and that hormonal shifts across the menstrual cycle can trigger longer and more severe attacks.The company shares research findings about ...
Pfizer stock holds at $24.84 as company shares rare cancer journey amid continued sideways trade
Pfizer shares a personal story from Isis Kanevsky, who is navigating treatment and survivorship following a rare cancer diagnosis.Kanevsky says her daughter is her driving force and what she is ...
Pfizer stock under pressure near yearly lows despite launch of new obesity study programs
Pfizer has dosed the first participants in its VESPER-6 and SOLIS-1 studies, part of activity in its obesity drug pipeline.The company plans to start more than 20 studies in its obesity pipeline ...
Sigvotatug vedotin trial failure sends Pfizer stock down nearly 3%
Pfizer (PFE) stock is trading at $23.98, closing down 2.99% for the day. The share price ended the session below its key moving averages, reflecting ongoing downside ...
-3.08% for Pfizer stock as CFO Dave Denton steps down
Pfizer Inc. (PFE) stock is trading at $25.17, down 3.08% on the day. The price remains below its key moving averages, reflecting continued pressure in the current ...
Pfizer stock climbs as dividend yield attracts income investors
Pfizer Inc. (PFE) stock is trading at $26.26, up 2.56% on the day. The stock sits above its main short-term and long-term moving averages, reflecting positive momentum ...
Pfizer stock edges higher to $25.66 as Pfizer presents blood disorder data at EHA2026
Pfizer is presenting more than 20 abstracts at EHA2026 in Stockholm this week.The company is focusing on blood cancers, sickle cell disease, and hemophilia. Pfizer states it is committed to ...
Pfizer advances obesity treatment pipeline as stock trades near weekly highs
Pfizer announced new Phase 2b data for its investigational GLP‑1 RA peptide, showing robust efficacy and favourable gastrointestinal tolerability with weekly and monthly dosing.The company said ...
Pfizer stock sees mild rebound above $25.98 but upside momentum capped near resistance
Pfizer stated that not all migraine attacks are random and that hormonal shifts during the menstrual cycle can trigger longer, more severe symptoms.The company said that understanding the science ...
Pfizer stock edges higher 1.32% as company announces new Phase 2b obesity data at ADA event
Pfizer announced that new Phase 2b data from its obesity pipeline will be presented at a late-breaking expert symposium during the #ADASciSessions this weekend.Pfizer stated that it is working to ...
Selling pressure pushes Pfizer stock lower in today's trading
Pfizer Inc. (PFE) is trading at $25.65, down 2.12% on the day. The stock sits just below its 20-day moving average at $25.98 and well under the 50-day at $26.73, but remains slightly above the ...
-3.15% for Pfizer stock as new share registration weighs on outlook
Pfizer Inc. (PFE) is trading at $25.65, marking a daily decline of 3.15%. The asset is currently positioned below its key moving averages, which reflects sustained ...
